PURPOSE: To determine whether children with type I osteogenesis imperfecta (OI) exhibit ankle plantar flexor weakness and whether this correlates with physical function. METHODS: Twenty children and adolescents with type I OI and 20 age-matched controls (age 6-18 years) participated in a single evaluation session. Data included strength assessment, Gillette Functional Assessment Questionnaire, Pediatric Outcome Data Collection Instrument (PODCI), and Faces Pain Scale-Revised. RESULTS: Ankle plantar flexor weakness was evident in the OI group compared with the control group. Heel-rise strength correlated with ankle isometric plantar flexion strength. Limitations in PODCI subscales-sports and physical function and pain/comfort-are present in the OI group. CONCLUSION: Ankle plantar flexor weakness is present in children and adolescents with type I OI and correlates with function. Gillette Functional Assessment Questionnaire, PODCI, and strength assessment are valuable evaluation tools for children and adolescents with type I OI and can aid therapists in goal setting.
PURPOSE: To determine whether children with type I osteogenesis imperfecta (OI) exhibit ankle plantar flexor weakness and whether this correlates with physical function. METHODS: Twenty children and adolescents with type I OI and 20 age-matched controls (age 6-18 years) participated in a single evaluation session. Data included strength assessment, Gillette Functional Assessment Questionnaire, Pediatric Outcome Data Collection Instrument (PODCI), and Faces Pain Scale-Revised. RESULTS:Ankle plantar flexor weakness was evident in the OI group compared with the control group. Heel-rise strength correlated with ankle isometric plantar flexion strength. Limitations in PODCI subscales-sports and physical function and pain/comfort-are present in the OI group. CONCLUSION:Ankle plantar flexor weakness is present in children and adolescents with type I OI and correlates with function. Gillette Functional Assessment Questionnaire, PODCI, and strength assessment are valuable evaluation tools for children and adolescents with type I OI and can aid therapists in goal setting.
Authors: Keren Machol; Trevor D Hadley; Jake Schmidt; David Cuthbertson; Henri Traboulsi; Rodrigo C Silva; Chloe Citron; Sobiah Khan; Kate Citron; Erin Carter; Kenneth Brookler; Jay R Shapiro; Robert D Steiner; Peter H Byers; Francis H Glorieux; Michaela Durigova; Peter Smith; Michael B Bober; Vernon R Sutton; Brendan H Lee; Sandesh C S Nagamani; Cathleen Raggio Journal: Am J Med Genet A Date: 2019-12-26 Impact factor: 2.802
Authors: Youngjae Jeong; Stephanie M Carleton; Bettina A Gentry; Xiaomei Yao; J Andries Ferreira; Daniel J Salamango; MaryAnn Weis; Arin K Oestreich; Ashlee M Williams; Marcus G McCray; David R Eyre; Marybeth Brown; Yong Wang; Charlotte L Phillips Journal: J Bone Miner Res Date: 2015-05-14 Impact factor: 6.741
Authors: Christopher S Constantino; Joseph J Krzak; Alissa V Fial; Karen M Kruger; Jacob R Rammer; Katarina Radmanovic; Peter A Smith; Gerald F Harris Journal: JBMR Plus Date: 2019-10-18
Authors: Emily L Germain-Lee; Feng-Shu Brennen; Diana Stern; Aditi Kantipuly; Pamela Melvin; Mia S Terkowitz; Jay R Shapiro Journal: Pediatr Res Date: 2015-11-05 Impact factor: 3.756
Authors: Karen M Kruger; Angela Caudill; Mercedes Rodriguez Celin; Sandesh C S Nagamani; Jay R Shapiro; Robert D Steiner; Michael B Bober; Tracy Hart; David Cuthbertson; Jeff Krischer; Peter H Byers; Michaela Durigova; Francis H Glorieux; Frank Rauch; V Reid Sutton; Brendan Lee; Eric T Rush; Peter A Smith; Gerald F Harris Journal: Genet Med Date: 2019-03-28 Impact factor: 8.822